How to Read a Certificate of Analysis (CoA): A Step-by-Step Guide for Researchers

A Certificate of Analysis (CoA) is a formal document issued by a manufacturer or testing laboratory that reports the results of analytical testing performed on a specific batch of material. In the context of research peptides, the CoA serves as the primary quality record, providing evidence that the peptide has been tested for identity, purity, and other quality attributes. The CoA is specific to a single production batch — each batch should have its own unique CoA with batch-specific analytical data.

The CoA originates from pharmaceutical manufacturing practice, where regulatory frameworks such as ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients) and FDA 21 CFR Part 211 require documented evidence of quality testing for every batch of drug substance. While research-grade peptides are not subject to these regulations, the CoA format has been adopted as the industry-standard quality document for communicating analytical results to researchers.

A complete and reliable CoA should contain the following elements:

• Product identification: peptide name, amino acid sequence, molecular formula, and CAS number (if applicable)
• Batch/lot number: a unique identifier linking the CoA to a specific production run
• Date of manufacture and date of analysis
• HPLC purity: percentage purity with method details and chromatogram
• Mass spectrometry data: observed and theoretical molecular weight
• Net peptide content: actual peptide mass as percentage of total weight (if amino acid analysis was performed)
• Physical description: appearance of the lyophilized material
• Storage recommendations: temperature and conditions for maintaining stability
• Laboratory identification: name of the analyst, laboratory, or quality control department
• Signature or authorization: indication that the results have been reviewed and approved

Begin by confirming that the CoA corresponds to the peptide you ordered. Check that the peptide name matches your order, the amino acid sequence is correct (compare letter by letter against a reference such as UniProt or published literature), and the molecular formula is consistent with the sequence. Calculate the theoretical molecular weight from the sequence and compare it to the value reported on the CoA. The theoretical monoisotopic mass can be calculated by summing the residue masses and adding 18.015 Da for the terminal water molecule.

Verify the batch/lot number on the CoA matches the label on the product vial. If they do not match, the CoA may not represent the material you received. This is a fundamental traceability requirement — without matching batch numbers, the CoA has no evidentiary value for your specific sample.

The HPLC purity value is the most commonly reported quality metric for research peptides. It represents the percentage of the total chromatographic peak area attributable to the target peptide, with the remainder representing impurities (deletion sequences, truncated forms, oxidized variants, or other synthesis-related byproducts).

When evaluating HPLC data, check for the following:

• Purity percentage: Research-grade peptides typically require ≥95% purity. Values below 90% may indicate substandard synthesis or purification. Values above 99% for peptides longer than 25 residues should be viewed with healthy skepticism.
• Chromatogram included: The actual HPLC trace (chromatogram) should accompany the numerical purity value. A percentage without the chromatogram is an unverifiable claim. The chromatogram should show a dominant single peak with a clean baseline.
• Method details: The CoA should specify the column type (C18 is standard), mobile phase composition (typically water/acetonitrile with 0.1% TFA), gradient program, flow rate, detection wavelength (214 nm for peptide bond absorption), and column temperature.
• Peak symmetry: The main peak should be reasonably symmetric (symmetry factor 0.8-1.5). Severe tailing or fronting may indicate sample degradation or chromatographic problems.
• Retention time: Should be reasonable for the peptide hydrophobicity (typically 10-30 minutes for analytical methods). Very early or very late elution may indicate method issues.

Mass spectrometry (MS) confirms the molecular identity of the peptide — it answers the question of whether the sample is actually the compound you ordered, as opposed to a different peptide or degradation product that might co-elute at a similar HPLC retention time.

The CoA should report both the theoretical (calculated) molecular weight and the observed molecular weight from the MS measurement. For electrospray ionization MS (ESI-MS), which is the most common technique for peptide analysis, the observed mass should match the theoretical mass within ±1 Da for standard instruments or ±0.5 Da for high-resolution instruments. For MALDI-TOF MS, mass accuracy is typically ±0.1% of the molecular weight.

Common mass discrepancies and their explanations:

• +16 Da: Methionine oxidation (Met → Met sulfoxide). Common for methionine-containing peptides exposed to air.
• -17 or -18 Da: Deamidation of asparagine or glutamine residues, or loss of water from the peptide.
• +22 Da: Sodium adduct [M+Na]⁺ instead of proton adduct [M+H]⁺. An instrumental artifact, not a sample problem.
• +38 Da: Potassium adduct [M+K]⁺. Similar to sodium adducts.
• +114 Da: TFA adduct. The trifluoroacetate counter-ion from HPLC purification forming a non-covalent complex.
• Mass deficit equal to a specific amino acid residue: Deletion sequence — one amino acid was missed during synthesis.

Net peptide content (NPC) represents the actual mass of peptide in the sample, expressed as a percentage of the total weighed mass. This is distinct from HPLC purity: a sample can be 98% pure by HPLC but contain only 70% net peptide content, because the remaining 30% consists of counter-ions (typically TFA salts), residual water, and trace solvents — not peptide impurities.

Typical net peptide content for lyophilized research peptides ranges from 60% to 85%. The primary non-peptide components are trifluoroacetate counter-ions (which can constitute 15-30% of the total mass for highly basic peptides with multiple arginine or lysine residues) and residual moisture (typically 2-8%).

Depending on the intended application, additional analytical data may appear on comprehensive CoAs:

• Endotoxin testing (LAL assay): Reports bacterial endotoxin levels in Endotoxin Units per milligram (EU/mg). Essential for peptides used in cell culture or in vivo research. Acceptable limits: <1 EU/mg for general research, <0.25 EU/mg for cell culture applications, per USP <85> guidelines.
• Residual solvent analysis: Quantifies organic solvents remaining from synthesis and purification. ICH Q3C(R8) defines acceptable limits by solvent class. Class 2 solvents (acetonitrile, DMF) have specific concentration limits; Class 3 solvents (ethanol, acetone) are generally regarded as less toxic.
• Water content (Karl Fischer titration): Measures residual moisture in the lyophilized sample. Values typically range from 2-8%. Excessive water content (>10%) may indicate incomplete lyophilization and can accelerate degradation during storage.
• Amino acid composition: Confirms that the correct amino acids are present in the expected ratios. Provides additional identity confirmation beyond molecular weight.
• Peptide sequence verification (MS/MS or Edman degradation): Definitive sequence confirmation by analyzing peptide fragment ions. The most conclusive identity test available but not routinely performed for research-grade material.

The credibility of a CoA is directly linked to the credibility of the laboratory that produced it. Check whether the CoA identifies the testing laboratory by name. If the analysis was performed in-house by the manufacturer, this represents a potential conflict of interest (the entity selling the product is also certifying its quality). Third-party analysis by an independent laboratory removes this conflict.

For third-party laboratories, verify accreditation status. ISO/IEC 17025 accreditation (the international standard for testing and calibration laboratory competence) demonstrates that the laboratory operates under a validated quality management system, uses calibrated and maintained instruments, employs qualified personnel, and participates in proficiency testing programs. The accreditation body and certificate number should be verifiable through the relevant national accreditation body website.

The distinction between in-house and third-party CoAs is the single most important factor in CoA reliability assessment:

• In-house CoA: Analytical testing performed by the manufacturer quality control department. Advantages: typically included with every product at no additional cost, fast turnaround. Limitations: inherent conflict of interest, no independent verification, quality depends entirely on the manufacturer internal standards.
• Third-party CoA: Analytical testing performed by an independent laboratory with no financial relationship to the manufacturer. Advantages: eliminates conflict of interest, accredited laboratories follow standardized validated methods, results are independently verifiable. Limitations: additional cost, longer turnaround time, not always available for every batch.

• Template CoAs: If you order the same peptide twice from the same supplier and receive CoAs with identical HPLC retention times, peak areas, and MS spectra, the documents are likely pre-made templates rather than actual batch-specific analyses. Genuine analytical data produces unique values for each batch.
• Missing chromatogram: A purity percentage without the supporting HPLC chromatogram cannot be independently evaluated. The chromatogram is the primary evidence — the percentage is derived from it.
• No batch number: Without a unique batch identifier, the CoA cannot be traced to a specific production run. This makes verification impossible and suggests inadequate quality documentation practices.
• Rounded or identical values across products: If a supplier reports exactly 98.0% purity for every peptide in their catalog, this is statistically improbable and suggests the values are fabricated rather than measured.
• Inconsistent molecular weights: If the theoretical and observed molecular weights on the CoA differ by more than ±2 Da (for standard ESI-MS), the sample may not be the claimed peptide, or the MS data may have been copied from a different analysis.
• No analysis date: A CoA without an analysis date has no temporal context. For peptides that degrade over time, the analysis date relative to the shipping date is relevant to assessing whether the reported purity still reflects the current state of the sample.
• Generic laboratory name or no laboratory identified: Phrases like 'tested by our quality department' without a specific laboratory name or analyst identifier reduce traceability and accountability.

Yes. Common fabrication indicators include CoAs that lack original HPLC chromatograms, reuse identical purity values across different batches, show suspiciously perfect results (e.g., 99.9% purity on complex peptides), or lack batch-specific lot numbers. Cross-referencing vendor CoAs with third-party lab results on ChemVerify helps identify inconsistencies.

Start with the batch/lot number — it should be unique and match your product label. Then verify the molecular weight via mass spectrometry matches the expected value within ±1 Da. Next, examine the HPLC chromatogram for a single dominant peak with good resolution. Finally, check net peptide content, as it directly affects your concentration calculations.

An in-house CoA is generated by the peptide manufacturer using their own analytical equipment. A third-party CoA comes from an independent laboratory with no financial interest in the product. Third-party CoAs provide unbiased verification and are considered significantly more reliable. Leading independent labs include Janoshik Analytical (Czech Republic) and MZ Biolabs (Germany).

Every batch should have its own CoA. Even when reordering the same peptide from the same vendor, batch-to-batch variation in purity, net peptide content, and impurity profiles is normal. Never assume a previous CoA applies to a new shipment — always request batch-specific documentation.

Explore detailed chemical profiles and research guides for compounds discussed in this article:

• BPC-157: Complete Research Guide → /learn/bpc-157
• GHK-Cu: Complete Research Guide → /learn/ghk-cu
• TB-500: Complete Research Guide → /learn/tb-500

• Read more: Peptide Purity vs Net Peptide Content (NPC): The Critical Difference Explained → https://www.chemverify.com/learn/peptide-purity-vs-net-peptide-content-npc
• Read more: Complete Guide to Peptide Purity Testing: HPLC, Mass Spectrometry & CoA Verification → https://www.chemverify.com/learn/peptide-purity-testing-guide
• Read more: HPLC Column Selection Guide for Peptide Analysis → https://www.chemverify.com/learn/hplc-column-selection-guide
• Read more: Research Peptide Vendor Verification: The Complete Quality Checklist → https://www.chemverify.com/learn/vendor-verification-checklist